Radar > 225795

Aspen Pharma do Brasil to invest in factory and does not rule out acquisitions in 2016

Aspen Pharma do Brasil vai investir em fábrica e não descarta aquisições para 2016

Intel ID : 225795
Synopsis

Aspen Pharma do Brasil, a subsidiary of South Africa-based Aspen Pharmacare (SJ:APN) with headquarters in Rio de Janeiro, will invest BRL 200m in factory Serra, in Espírito Santo state, in the next five years, as published by Valor Econômico on 1 June 2015, quoting company's CEO.

The investment will be used to double the unit's size and its storage capacity.

According to Aspen Pharma do Brasil's CEO, Alexandre Françam "as of next year, Aspen will continue to look at possible acquisition opportunities, but also intends to launch products developed at its units". In addition, he says "this is maybe the big change with respect to previous years".
(content in portuguese)

A Aspen Pharma do Brasil, subsidiária da sul-africana Aspen Pharmacare (SJ:APN) e com sede no Rio de Janeiro, vai investir BRL 20m na fábrica de Serra, no estado do Espírito Santo, nos próximos cincos anos, publicou o Valor Econômico em 1 de junho de 2015, citando à um executivo da empresa.

O investimento será utilizado para quase duplicar a unidade, e também, na capacidade de armazenagem da empresa farmacêutica no Brasil.

De acordo com o Executivo da Aspen Pharma do Brasil, Alexandre Françam "a partir do próximo ano, a Aspen continua olhando possíveis compras, mas também pretende lançar produtos desenvolvidos em seus centros". Além disso, ele resalta, "Essa talvez seja a grande mudança em relação aos anos anteriores".

Bidder

Ultimate Owner (Buyer)

Aspen Pharma
South Africa

Intel ID 225795
Value EUR 5,70m
Native Currency Brazilian Real (BRL)
Exchange Rate:
Date
Country
Region
Continent
Geography
Subsector (Old TTR Sectors)
Type
Intel Grade
Source
Tags

Bidder

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Ultimate Owner (Buyer)

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.